Cargando…
Potassium 2-(1-hydroxypentyl)-benzoate improves depressive-like behaviors in rat model
Potassium 2-(1-hydroxypentyl)-benzoate (PHPB) is a novel drug candidate for acute ischemic stroke. PHPB has been also shown to be beneficial for some neurodegenerative diseases. In this study, we demonstrated that PHPB improved depressive-like behaviors induced by chronic unpredictable mild stress (...
Autores principales: | Ma, Hao, Wang, Weiping, Xu, Shaofeng, Wang, Ling, Wang, Xiaoliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251814/ https://www.ncbi.nlm.nih.gov/pubmed/30505657 http://dx.doi.org/10.1016/j.apsb.2018.08.004 |
Ejemplares similares
-
The attenuation effect of potassium 2‐(1‐hydroxypentyl)‐benzoate in a mouse model of diabetes‐associated cognitive decline: The protein expression in the brain
por: Yu, Wenwen, et al.
Publicado: (2022) -
Potassium 2-(1-hydroxypentyl)-benzoate attenuates neuronal apoptosis in neuron–astrocyte co-culture system through neurotrophy and neuroinflammation pathway
por: Liu, Dongmei, et al.
Publicado: (2017) -
Potassium 2-(l-hydroxypentyl)-benzoate attenuates neuroinflammatory responses and upregulates heme oxygenase-1 in systemic lipopolysaccharide-induced inflammation in mice
por: Zhao, Chunyang, et al.
Publicado: (2017) -
Protective Effects of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate in a Rodent Model of Global Cerebral Ischemia
por: Gao, Yuan, et al.
Publicado: (2017) -
LC-MS/MS Analysis and Pharmacokinetics of Sodium (±)-5-Bromo-2-(α-hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-Ischemic Stroke Agent in Rats
por: Tian, Xin, et al.
Publicado: (2016)